New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 17, 2012
10:27 EDTSJM, VLO, HFC, RP, ITRI, MHS, UPL, AIMC, ARTC, JWN, ACOR, HSP, MXWL, DELLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Dell (DELL) downgraded to Neutral from Outperform at RW Baird...Maxwell Tech (MXWL) downgraded to Neutral from Outperform at RW Baird...Hospira (HSP) downgraded to Sell from Neutral at Citigroup...Acorda Therapeutics (ACOR) downgraded to Neutral from Buy at Citigroup...Nordstrom (JWN) downgraded to Underperform from Buy at CLSA...ArthroCare (ARTC) downgraded to Hold from Buy at Jefferies...Altra Holdings (AIMC) downgraded to Hold from Buy at Jefferies...Ultra Petroleum (UPL) downgraded to Hold from Buy at Jefferies...Medco Health (MHS) downgraded to Equal Weight from Overweight at Morgan Stanley...Itron (ITRI) downgraded to Hold from Buy at KeyBanc...RealPage (RP) downgraded to Sector Perform from Outperform at Pacific Crest...HollyFrontier (HFC) downgraded to Neutral from Buy at UBS...Valero Energy (VLO) downgraded to Neutral from Buy at UBS...J.M. Smucker (SJM) downgraded to Buy from Conviction Buy at Goldman.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 25, 2014
05:31 EDTJWNNordstrom store in Canada off to strong start, says Deutsche Bank
Deutsche Bank says the feedback received regarding Nordstrom's first store opening in Canada has been "particularly favorable." Deutsche expects Canada to eventually add 30c-40c to Nordstrom's bottom line and contribute up to $6 in value to the stock. The firm reiterates a Buy rating on the name with a $77 price target.
September 24, 2014
16:22 EDTACOROn The Fly: Closing Wrap
Stocks on Wall Street were higher after a report showed that sales of new homes rose to their highest level in over six years in August. The volume and news flow were relatively light, which may be the case again tomorrow as many market participants celebrate the Jewish holiday of Rosh Hashanah. ECONOMIC EVENTS: In the U.S., new home sales rose 18.0% in August to a 504K unit rate, which was much higher than the expected 4.4% increase. COMPANY NEWS: Bed Bath & Beyond (BBBY) advanced $4.64, or 7.4%, to $67.33 after the home goods retailer last night reported second quarter earnings and revenue that surpassed analysts' consensus estimates. The better than expected report and rise in the stock comes a day after William Blair downgraded the stock yesterday morning... Citizen Financial (CFG), the U.S. retail bank unit of Royal Bank of Scotland (RBS), became the year's second largest IPO behind Alibaba (BABA) after 140M shares began trading on the NYSE this morning. The stock ended it first day up $1.58, or 7.35%, at $23.08, which was far cry from the advance seen by another of the day's new stock debuts. CyberArk (CYBR) priced 5.36M shares at $16.00, opened for trade at $25.00 and ended the day at $29.94, making for a rise of over 87% from its IPO pricing. MAJOR MOVERS: Among the notable gainers was Acorda Therapeutics (ACOR), which advanced $8.27, or 28.18%, to $37.62 after the company agreed to acquire Civitas Therapeutics for $525M in cash. Civitas, which was private, had been scheduled to come public via an IPO that was expected to happen later this week prior to the deal announcement. Also higher was Hasbro (HAS), which rose $2.01, or 3.8%, to $54.95 after striking a deal that gives the company global rights, excluding Japan, to develop dolls based on Disney's (DIS) princess characters, as well as Frozen, beginning in 2016. Mattel (MAT), which currently holds those rights, slid 40c, or 1.25%, to $31.67 in the wake of the news. Also lower were shares of Skechers (SKX), which fell $5.69, or 9.8%, to $52.40 after research firm SportscanInfo reported that the footwear maker's sales had fallen 3% last week. However, Sterne Agee recommended buying the stock on the weakness. INDEXES: The Dow rose 154.19, or 0.9%, to 17,210.06, the Nasdaq gained 46.53, or 1.03%, to 4,555.22, and the S&P 500 added 15.53, or 0.78%, to 1,998.30.
13:49 EDTACORAcorda Therapeutics price target raised to $65 from $52 at Cowen
Subscribe for More Information
12:29 EDTACOROn The Fly: Midday Wrap
Subscribe for More Information
10:38 EDTACORAcorda Therapeutics rallies on Civitas Therapeutics acquisition
Subscribe for More Information
09:52 EDTACORAlkermes expects to receive $59M in connection to Acorda-Civitas deal
Subscribe for More Information
09:34 EDTVLOActive equity options trading on open
Subscribe for More Information
09:05 EDTACOROn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTACORAcorda Therapeutics to host conference call
Subscribe for More Information
07:27 EDTACORAcorda acquires Civitas Therapeutics for $525M in cash
Subscribe for More Information
07:21 EDTACORAcorda Therapeutics trading halted, pending news
Subscribe for More Information
September 23, 2014
10:02 EDTVLO, HFCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:54 EDTHSPLeerink to hold a conference
Subscribe for More Information
06:05 EDTHFCHollyFrontier initiated with a Neutral at JPMorgan
Target $53.
06:05 EDTVLOValero initiated with a Neutral at JPMorgan
Target $59.
September 22, 2014
11:24 EDTHSPHospira, Orion amend settlement agreement over Precedex
Subscribe for More Information
08:46 EDTITRIItron, i2O Water announce new partnership
Itron announced a new alliance with i2O Water. The collaboration will expand Itronís water portfolio and round out its non-revenue water offering. Itron has signed a five-year agreement to distribute i2Oís Smart Pressure Management products.
September 18, 2014
09:50 EDTMXWLMaxwell management to meet with Northland
Meetings to be held in Chicago on September 22 and in Milwaukee on September 23 hosted by Northland.
September 17, 2014
10:48 EDTSJMHigh option volume stocks
Subscribe for More Information
08:56 EDTVLODarling Valero and Valero's Diamond Green Diesel facility restarting production
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use